0
0
6/10/23 at 3:08pm
Organization
The Guardian
Author
Edward Helmore
35 words
0
Comments
Panel’s opinion could pave way for full regulatory approval next month for treatment of disease that affects 6.5m Americans
You are the first to view
https://www.theguardian.com/us-news/2023/jun/10/lecanemab-leqembi-alzheimers-drug-fda-advisers
Create an account
or login to join the discussion